Insider Buying: Cytomedix Insider Purchases 40,000 Shares of Stock (CMXI)
Cytomedix (NASDAQ:CMXI) Insider Dean Tozer purchased 40,000 shares of Cytomedix stock on the open market in a transaction dated Friday, August 29th. The stock was purchased at an average price of $0.35 per share, for a total transaction of $14,000.00. Following the purchase, the insider now directly owns 126,700 shares in the company, valued at approximately $44,345. The transaction was disclosed in a filing with the SEC, which is available at this link.
Cytomedix (NASDAQ:CMXI) opened at 0.36 on Wednesday. Cytomedix has a 52-week low of $0.33 and a 52-week high of $0.68. The stock’s 50-day moving average is $0.39 and its 200-day moving average is $0.46. The company’s market cap is $44.8 million.
Cytomedix, Inc is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair.